Patent directory · USPTO A61K / A61P
Patents matching “glatiramer acetate”
19 pharma patents match "glatiramer acetate" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 19 pharmaceutical patents matching "glatiramer acetate" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9763993
Process for manufacturing glatiramer acetate product
granted -
US 9702007
Genetic markers predictive of response to glatiramer acetate
granted -
US 9687522
Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
granted -
US 9625473
Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate
granted -
US 9617596
Biomarkers predictive for clinical response for glatiramer acetate
granted -
US 9499868
Determination of single nucleotide polymorphisms useful to predict response for glatiramer acetate
granted -
US 9155775
Process for manufacturing glatiramer acetate product
granted -
US 9063153
Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate
granted -
US 9018170
Reduced volume formulation of glatiramer acetate and methods of administration
granted -
US 8920373
Reduced volume formulation of glatiramer acetate and methods of administration
granted -
US 8815511
Determination of single nucleotide polymorphisms useful to predict response for glatiramer acetate
granted -
US 8759302
Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
granted -
US 8709433
Cytokine biomarkers as predictive biomarkers of clinical response for Glatiramer acetate
granted -
US 8389228
Process for the measurement of the potency of glatiramer acetate
granted -
US 7968511
Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis
granted -
US 7923215
Process for the measurement of the potency of glatiramer acetate
granted -
US 7855176
Reduced volume formulation of glatiramer acetate and methods of administration
granted -
US 7429374
Process for the measurement of the potency of glatiramer acetate
granted -
US 7033582
Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
expired